Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 5/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.34 |
| ▸ | APLNR | P35414 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL571467 | 0.82 | CTSK (0.40) | CTSKTDP1CA1CA2CA7 | |
| SCHEMBL20159624 | 0.82 | CTSK (0.40) | CTSKTDP1CA1CA2CA7 | |
| SCHEMBL16061377 | 0.82 | CTSK (0.40) | CTSKTDP1CA1CA2CA7 | |
| SCHEMBL2902461 | 0.82 | CTSK (0.36) | CTSKTDP1CA1CA2CA7 | |
| SCHEMBL15096829 | 0.81 | MAPK10 (0.41) | CTSKTDP1CA1CA2CA7 | |
| SCHEMBL12571335 | 0.81 | MAPK10 (0.41) | CTSKTDP1CA1CA2CA7 | |
| SCHEMBL2877516 | 0.81 | CTSK (0.39) | CTSKTDP1CA1CA2CA7 | |
| SCHEMBL10435327 | 0.80 | TDP1 (0.39) | CTSKTDP1CA1CA2CA7 | |
| SCHEMBL10776406 | 0.79 | CA1 (0.40) | CTSKTDP1CA1CA2CA7 | |
| SCHEMBL10100401 | 0.79 | CA1 (0.40) | CTSKTDP1CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005556-A | COX-2 targeted inhibition photosensitizer capable of activating tumor cell apoptosis and preparation method and application thereof | 大连理工大学 | 2024-05-10 | — | — | CN | claimed |
| CN-117384642-A | Selective etching solution | 湖北兴福电子材料股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-116354901-A | Thiazolidinedione compound and preparation method and application thereof | 郑州大学 | 2023-06-30 | — | — | CN | claimed |
| CN-118005556-A | COX-2 targeted inhibition photosensitizer capable of activating tumor cell apoptosis and preparation method and application thereof | 大连理工大学 | 2024-05-10 | — | — | CN | disclosed |
| CN-116354901-B | Thiazolidinedione compound and preparation method and application thereof | 郑州大学 | 2024-04-26 | — | — | CN | disclosed |
| CN-117088864-A | Benzo [ d ] isoxazole compound and application thereof | 广州智药生物科技有限公司 | 2023-11-21 | — | — | CN | disclosed |
| CN-116354901-A | Thiazolidinedione compound and preparation method and application thereof | 郑州大学 | 2023-06-30 | — | — | CN | disclosed |
| CN-110291849-B | Wiring forming method | 日产化学株式会社 | 2023-06-06 | — | — | CN | disclosed |
| US-10597491-B2 | Metal fine particle dispersant containing branched polymer compound having ammonium group | NISSAN CHEMICAL CORPORATION (JP) | 2020-03-24 | — | — | US | disclosed |
| EP-3190207-B1 | PHOTOCURABLE ELECTROLESS PLATING PRIMER | NISSAN CHEMICAL CORP (JP) | 2019-05-08 | — | — | EP | disclosed |
| US-9893366-B2 | Metal fine particle association and method for producing the same | NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY (JP) | 2018-02-13 | — | — | US | disclosed |
| EP-2698448-A1 | ELECTROLESS PLATING PRIMER INCLUDING HYPERBRANCHED POLYMER AND METALLIC MICROPARTICLES | Nissan Chemical Industries, Ltd. (JP) | 2014-02-19 | — | — | EP | disclosed |
| US-8338554-B2 | Hyperbranched polymer and method for producing the same | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-12-25 | — | — | US | disclosed |
| US-20110183837-A1 | METAL FINE PARTICLE DISPERSANT CONTAINING BRANCHED POLYMER COMPOUND HAVING AMMONIUM GROUP | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-07-28 | — | — | US | disclosed |
| EP-2332640-A1 | METAL MICROPARTICLE-DISPERSING AGENT COMPRISING BRANCHED POLYMERIC COMPOUND HAVING AMMONIUM GROUP | Nissan Chemical Industries, Ltd. (JP) | 2011-06-15 | — | — | EP | disclosed |
| US-20100048845-A1 | Hyperbranched polymer and method for producing the same | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-02-25 | — | — | US | disclosed |
| EP-2058338-A1 | HYPERBRANCHED POLYMER AND METHOD FOR PRODUCING THE SAME | Nissan Chemical Industries, Ltd. (JP) | 2009-05-13 | — | — | EP | disclosed |
| US-7094789-B2 | 5-substituted isoquinoline derivatives | ASAHI KASEI PHARMA CORPORATION (JP) | 2006-08-22 | — | — | US | disclosed |
| EP-1541559-A1 | 5-SUBSTITUTED ISOQUINOLINE DERIVATIVE | Asahi Kasei Pharma Corporation (JP) | 2005-06-15 | — | — | EP | disclosed |
| US-20050020623-A1 | 5-Substituted isoquinoline derivatives | ASAHI KASEI PHARMA CORPORATION (JP) | 2005-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020623-A1 | 5-Substituted isoquinoline derivatives | MYLK, MYLK2, MYL12A | CTSK 4434/4885TDP1 2039/4885CA1 3439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.